vs

Side-by-side financial comparison of California Resources Corp (CRC) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $119.0M, roughly 1.2× California Resources Corp). OPKO HEALTH, INC. produced more free cash flow last quarter ($-28.6M vs $-32.0M). Over the past eight quarters, OPKO HEALTH, INC.'s revenue compounded faster (-7.5% CAGR vs -46.3%).

California Resources Corporation is an American energy corporation engaged in hydrocarbon exploration in California. It is organized in Delaware and headquartered in Long Beach, California. Its mineral acreage holdings in California constitute the largest privately held position in the state.

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

CRC vs OPK — Head-to-Head

Bigger by revenue
OPK
OPK
1.2× larger
OPK
$148.5M
$119.0M
CRC
More free cash flow
OPK
OPK
$3.4M more FCF
OPK
$-28.6M
$-32.0M
CRC
Faster 2-yr revenue CAGR
OPK
OPK
Annualised
OPK
-7.5%
-46.3%
CRC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CRC
CRC
OPK
OPK
Revenue
$119.0M
$148.5M
Net Profit
$-31.3M
Gross Margin
43.1%
Operating Margin
-597.5%
-25.8%
Net Margin
-21.1%
Revenue YoY
-19.2%
Net Profit YoY
-322.8%
EPS (diluted)
$-8.02
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRC
CRC
OPK
OPK
Q1 26
$119.0M
Q4 25
$679.0M
$148.5M
Q3 25
$715.0M
$151.7M
Q2 25
$702.0M
$156.8M
Q1 25
$814.0M
$150.0M
Q4 24
$826.0M
$183.6M
Q3 24
$870.0M
$173.6M
Q2 24
$412.0M
$182.2M
Net Profit
CRC
CRC
OPK
OPK
Q1 26
Q4 25
$12.0M
$-31.3M
Q3 25
$64.0M
$21.6M
Q2 25
$172.0M
$-148.4M
Q1 25
$115.0M
$-67.6M
Q4 24
$33.0M
$14.0M
Q3 24
$345.0M
$24.9M
Q2 24
$8.0M
$-10.3M
Gross Margin
CRC
CRC
OPK
OPK
Q1 26
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Operating Margin
CRC
CRC
OPK
OPK
Q1 26
-597.5%
Q4 25
6.9%
-25.8%
Q3 25
13.7%
31.7%
Q2 25
38.0%
-38.3%
Q1 25
22.9%
-44.8%
Q4 24
8.2%
-18.0%
Q3 24
59.5%
8.2%
Q2 24
9.2%
-33.9%
Net Margin
CRC
CRC
OPK
OPK
Q1 26
Q4 25
1.8%
-21.1%
Q3 25
9.0%
14.3%
Q2 25
24.5%
-94.7%
Q1 25
14.1%
-45.1%
Q4 24
4.0%
7.6%
Q3 24
39.7%
14.3%
Q2 24
1.9%
-5.7%
EPS (diluted)
CRC
CRC
OPK
OPK
Q1 26
$-8.02
Q4 25
$0.21
$-0.04
Q3 25
$0.76
$0.03
Q2 25
$1.92
$-0.19
Q1 25
$1.26
$-0.10
Q4 24
$0.87
$0.02
Q3 24
$3.78
$0.03
Q2 24
$0.11
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRC
CRC
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$2.9B
$1.3B
Total Assets
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRC
CRC
OPK
OPK
Q1 26
Q4 25
$132.0M
$364.4M
Q3 25
$196.0M
$412.0M
Q2 25
$72.0M
$267.3M
Q1 25
$214.0M
$428.8M
Q4 24
$372.0M
$426.6M
Q3 24
$241.0M
$400.1M
Q2 24
$1.0B
$40.6M
Total Debt
CRC
CRC
OPK
OPK
Q1 26
Q4 25
$344.0M
Q3 25
$1.0B
$344.2M
Q2 25
$1.0B
$343.3M
Q1 25
$1.0B
$439.2M
Q4 24
$1.1B
$437.2M
Q3 24
$1.1B
$441.0M
Q2 24
$1.2B
$201.9M
Stockholders' Equity
CRC
CRC
OPK
OPK
Q1 26
$2.9B
Q4 25
$3.7B
$1.3B
Q3 25
$3.4B
$1.3B
Q2 25
$3.4B
$1.3B
Q1 25
$3.5B
$1.3B
Q4 24
$3.5B
$1.4B
Q3 24
$3.5B
$1.4B
Q2 24
$2.1B
$1.4B
Total Assets
CRC
CRC
OPK
OPK
Q1 26
Q4 25
$7.4B
$1.9B
Q3 25
$6.8B
$2.0B
Q2 25
$6.7B
$2.0B
Q1 25
$6.8B
$2.1B
Q4 24
$7.1B
$2.2B
Q3 24
$7.1B
$2.3B
Q2 24
$4.5B
$2.0B
Debt / Equity
CRC
CRC
OPK
OPK
Q1 26
Q4 25
0.27×
Q3 25
0.29×
0.26×
Q2 25
0.30×
0.26×
Q1 25
0.29×
0.33×
Q4 24
0.32×
0.32×
Q3 24
0.32×
0.31×
Q2 24
0.57×
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRC
CRC
OPK
OPK
Operating Cash FlowLast quarter
$99.0M
$-25.9M
Free Cash FlowOCF − Capex
$-32.0M
$-28.6M
FCF MarginFCF / Revenue
-26.9%
-19.3%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$380.0M
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRC
CRC
OPK
OPK
Q1 26
$99.0M
Q4 25
$235.0M
$-25.9M
Q3 25
$279.0M
$-34.6M
Q2 25
$165.0M
$-83.4M
Q1 25
$186.0M
$-34.6M
Q4 24
$206.0M
$-44.4M
Q3 24
$220.0M
$-77.1M
Q2 24
$97.0M
$-26.4M
Free Cash Flow
CRC
CRC
OPK
OPK
Q1 26
$-32.0M
Q4 25
$115.0M
$-28.6M
Q3 25
$188.0M
$-37.8M
Q2 25
$109.0M
$-86.7M
Q1 25
$131.0M
$-37.7M
Q4 24
$118.0M
$-49.8M
Q3 24
$141.0M
$-85.0M
Q2 24
$63.0M
$-33.7M
FCF Margin
CRC
CRC
OPK
OPK
Q1 26
-26.9%
Q4 25
16.9%
-19.3%
Q3 25
26.3%
-24.9%
Q2 25
15.5%
-55.3%
Q1 25
16.1%
-25.2%
Q4 24
14.3%
-27.1%
Q3 24
16.2%
-49.0%
Q2 24
15.3%
-18.5%
Capex Intensity
CRC
CRC
OPK
OPK
Q1 26
Q4 25
17.7%
1.8%
Q3 25
12.7%
2.1%
Q2 25
8.0%
2.1%
Q1 25
6.8%
2.1%
Q4 24
10.7%
2.9%
Q3 24
9.1%
4.6%
Q2 24
8.3%
4.0%
Cash Conversion
CRC
CRC
OPK
OPK
Q1 26
Q4 25
19.58×
Q3 25
4.36×
-1.60×
Q2 25
0.96×
Q1 25
1.62×
Q4 24
6.24×
-3.17×
Q3 24
0.64×
-3.10×
Q2 24
12.13×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRC
CRC

Segment breakdown not available.

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons